Debevoise & Plimpton LLP is advising Guggenheim Securities as financial advisor to Corium International, Inc., a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, in its sale to Gurnet Point Capital.

The Debevoise team is led by partner Andrew L. Bab and includes associates Zachary P. Ainsztein and Claire Hansen Suni.

Debevoise & Plimpton LLP is a premier law firm with market-leading practices, a global perspective and strong New York roots. We deliver effective solutions to our clients’ most important legal challenges, applying clear commercial judgment and a distinctively collaborative approach.